drugset / Trial / NCT03604016
Study to Assess Efficacy of Besifovir and L-carnitine in Chronic Hepatitis B Patients With Nonalcoholic Fatty Liver
RandomizedParallel-groupOpen-labelTreatment
Summary
Pilot study to assess the antiviral activity and safety of Besifovir dipivoxil 150mg and L-carnitine 660mg compared to Tenofovir Alafenamide 25mg in chronic hepatitis B patients with Nonalcoholic fatty liver
Timeline
- Start
- 2018-09-23
- Primary completion
- 2020-07-30
- Completion
- 2020-07-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | L-carnitine | Other / unclassified | 330 mg | — |
| Subject | L-carnitine | Other / unclassified | 660 mg | — |
| Subject | LB80380 | Small molecule | 150 mg | — |
| Comparator | tenofovir alafenamide | Small molecule | 25 mg | — |